GlassScriptPhysician profile
John C Hornsby
NPI 1396701728
$1,124.30
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $681 · 2020: $179 · 2021: $177 · 2022: $87.42.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $147.78 | 2019-2021 | |
| Tris Pharma INC | $145.89 | 2021-2022 | |
| Novo Nordisk INC | $102.09 | 2019-2020 | |
| Lilly USA, LLC | $80.27 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $67.75 | 2019-2020 | |
| Abbott Laboratories | $63.94 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.17 | 2019 | |
| Astellas Pharma US INC | $48.51 | 2019 | |
| Pfizer INC. | $43.94 | 2019-2021 | |
| Glaxosmithkline, LLC. | $40.35 | 2019-2020 | |
| Amarin Pharma, INC. | $39.75 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $36.94 | 2019 | |
| Shire North American Group INC | $33.58 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.10 | 2019 | |
| Amgen INC. | $31.78 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $26.49 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $26.21 | 2019 | |
| Ironshore Pharmaceuticals INC. | $20.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.72 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.40 | 2019 | |
| Dexcom, INC. | $17.19 | 2019 | |
| Boston Scientific Corporation | $17.14 | 2019 | |
| Pacira Therapeutics, INC. | $11.04 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hornsby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.